On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device ...

Nelly Solutions, one of Europe's fastest-growing health and fintech companies, has successfully closed a 50 million Series B funding round. This capital will accelerate the company's mission to ...

In 2024, the FDA issued two significant guidance documents on Predetermined Change Control Plans (PCCPs), formalizing a ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” fourth quarter 2024 investor letter. A copy of the ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Nelly wants to become the biggest fintech startup in the healthcare industry. The Berlin-based startup is already working ...

Ideas: AI and democracy with Madeleine Daepp and Robert Osazuwa Ness ...

Korea designates 29 innovative medical devices, prioritizes GMP review for 2025 Korea identifies 29 cutting-edge health ...